Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Anticoagulation therapy for patients with atrial fibrillation.

× No keyword cloud information.

11 in total

1. Assessment of three schemes for stratifying stroke risk in patients with nonvalvular atrial fibrillation.

Authors: L A Pearce; R G Hart; J L Halperin
Journal: Am J Med Date: 2000-07 Impact factor: 4.965

2. Stroke risk in an elderly population with atrial fibrillation.

Authors: W M Feinberg; R A Kronmal; A B Newman; M A Kraut; E G Bovill; L Cooper; R G Hart
Journal: J Gen Intern Med Date: 1999-01 Impact factor: 5.128

3. Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors: A S Go; E M Hylek; L H Borowsky; K A Phillips; J V Selby; D E Singer
Journal: Ann Intern Med Date: 1999-12-21 Impact factor: 25.391

4. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis.

Authors: R G Hart; O Benavente; R McBride; L A Pearce
Journal: Ann Intern Med Date: 1999-10-05 Impact factor: 25.391

5. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators.

Authors: R G Hart; L A Pearce; R McBride; R M Rothbart; R W Asinger
Journal: Stroke Date: 1999-06 Impact factor: 7.914

6. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.

Authors: J J Caro; K M Flegel; M E Orejuela; H E Kelley; J L Speckman; K Migliaccio-Walle
Journal: CMAJ Date: 1999-09-07 Impact factor: 8.262

7. Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors: A Howitt; D Armstrong
Journal: BMJ Date: 1999-05-15

8. Use of antithrombotic measures for stroke prevention in atrial fibrillation.

Authors: I Perez; A Melbourn; L Kalra
Journal: Heart Date: 1999-11 Impact factor: 5.994

9. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation: a randomized controlled trial.

Authors: M Man-Son-Hing; A Laupacis; A M O'Connor; J Biggs; E Drake; E Yetisir; R G Hart
Journal: JAMA Date: 1999-08-25 Impact factor: 56.272

10. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials.

Authors:
Journal: Arch Intern Med Date: 1994-07-11

2 in total

1. Anticoagulation therapy for patients with atrial fibrillation.

Authors: S J Connolly
Journal: CMAJ Date: 2000-11-14 Impact factor: 8.262

2. Patients' perspectives on taking warfarin: qualitative study in family practice.

Authors: Guilherme Coelho Dantas; Barbara V Thompson; Judith A Manson; C Shawn Tracy; Ross E G Upshur
Journal: BMC Fam Pract Date: 2004-07-21 Impact factor: 2.497

2 in total